
|Videos|November 9, 2015
Continuing Treatment in Dementia Patients
Kalin M. Clifford, PharmD, BCPS, discusses the factors should be considered when determining whether or not a patient with advanced dementia should continue taking a memantine or cholinesterase inhibitor.
Advertisement
Kalin M. Clifford, PharmD, BCPS, discusses the factors should be considered when determining whether or not a patient with advanced dementia should continue taking a memantine or cholinesterase inhibitor.
This video was recorded at ASCP's Annual Meeting and Exhibition in Las Vegas, Nevada in October 2015.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pharmacy Is a Practice, Not Just a Place
2
Beyond mRNA: A Pharmacist’s Guide to the Full COVID-19 Vaccine Landscape
3
Gemcitabine Intravesical System in Practice: Operational Considerations for Oncology Pharmacists
4
Mosunetuzumab Plus Polatuzumab Achieves Nearly 80% Complete Response Rate in Mantle Cell Lymphoma After BTK Inhibitors
5




































































































